Amlodipine Plus Botulinum Toxin for Focal Dystonia
National Institute of Neurological Disorders and Stroke (NINDS)
Objective: To determine if the calcium channel blockers, amlodipine can augment the effect
of botulinum toxin injections in the treatment of focal dystonia.
Study Population: 20 patients with cervical dystonia
Design: Double-bind, placebo-controlled clinical trail.
Outcome measures: For patients: dystonia rating scales (Twistrs, Fahn-Marsden dystonia
scale, NINDS subjective patient rating scale), and hand grip strength. For healthy
volunteers: Amplitude of EDB MEP.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
This study examines botulinum toxin (BOTOX, or BTX) for the treatment of muscle twitches and
spasticity associated with cerebral palsy in children. Botulinum toxin is a naturally
occurring bacterial toxin (botulinum toxin) that inactivates certain parts of muscles.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.